Many individuals who suffer with joint disease, such as osteoarthritis, are unhappy with the current options available. Some of those current options include pharmaceutical pain management and surgical joint replacement. Although those treatments may be in the mainstream, many individuals are now looking to alternative treatments because they may be more effective and can produce results without the harmful side effects that may go along with traditional treatment.

As with anything in alternative medicine, it is best to be on the cutting edge and that is what you have available through OrthoFlo. It is an amniotic fluid derived allograft that can provide many benefits for individuals who suffer with joint disease. Taking a look at the primary benefits can show you that it is an option that you may want to consider discussing with your physician.

Primary Benefits of OrthoFlo:

• Protect and Cushion
• Provide lubrication
• Reduce inflammation

What Is OrthoFlo?

The amniotic fluid is beneficial for the baby because it helps to protect the baby as it moves about within the womb. It provides many natural functions, including enhancing the mobility of the unborn child. Amniotic fluid also contains a number of key elements including, carbohydrates, lipids, growth factors, proteins, electrolytes and many other key nutrients.

In addition to providing those and other nutrients, amniotic fluid also contains hyaluronic acid. This is an important factor for the viscosity and lubrication of synovial fluid. In fact, amniotic fluid contains many of the same compounds that you would find in healthy synovial fluid.

Why is it important to understand the benefits of amniotic fluid? Because OrthoFlo is an amniotic fluid derived allograft. When it is injected into the area where you are experiencing joint pain, it may supplement your existing synovial fluid and may enhance its ability to both protect and lubricate the area that is experiencing difficulties.

Regulatory Factors In Amniotic and Synovial Fluid

There have been a number of regulatory factors identified within both synovial and amniotic fluid. Two of the most important of those factors can clearly show you how OrthoFlo may be able to help, not only to reduce the difficulties you are experiencing as a result of joint disease but may even be able to help reverse some of the degeneration of cartilage in the area!

Interleukin 1 Receptor Antagonist - This is known to be involved in the degeneration of cartridge. Amniotic fluid may reduce Cartledge degeneration in this way.

Tissue Inhibitor of Metalloproteinases - Amniotic fluid may also inactivate certain matrix metalloproteinases, which may also be responsible for the degeneration of cartilage.

There are also a number of other regulatory proteins, chemokines, and cytokines found in OrthoFlo. Many of these may also be of benefit to individuals who are suffering from joint disease. Below is a partial list…

• Brain-Derived Neuropathic Factor
• Basic Fibroblast Growth Factor
• Epidermal Growth Factor
• Eotaxin
• Eotaxin-2
• Hepatocyte Growth Factor
• Insulin -like Growth Factor Binding Protein (1, 2, 3, 4 and 6)
• macrophage colony stimulating factor
• microfiche inhibitory factor
• Osteopontin
• Platelet Factor 4
• Transforming Growth Factor Alpha

How Is OrthoFlo Applied?

• OrthoFlo is for single use only
• OrthoFlo is a human amniotic fluid derived allograft. It is donated by mothers who have scheduled cesarean sections and are delivering healthy babies.
• OrthoFlo should be maintained at -80 C or colder until administration.
• OrthoFlo is given by injection by a licensed physician
• OrthoFlo is available in 4 size configurations. Your physician will choose the size that is best for your needs.

What about the Other Treatments?

There are other treatments available for joint disease, including platelet rich plasma and hyaluronic acid. Are these other alternative treatments as effective as OrthoFlo?

• Platelet Rich Plasma - This is a huge cash cow for the blood industry. By 2016, it is projected to be worth more than $120 million! There is no data available confirming that this method works.
• Hyaluronic Acid - This is also big business, with the hyaluronic acid industry forecast to reach 2.1 billion in 2016. Again, there is inconclusive clinical data to support hyaluronic acid.
• Corticosteroid Injections - At best, these injections provide limited and temporary reduction in osteoarthritis pain.

If you would like more information on OrthoFlo you can This email address is being protected from spambots. You need JavaScript enabled to view it..